Curiosis (494120.KQ) — Stock Score Summary

Curiosis (494120.KQ) has a MoatMap StockRank of 12/100 based on Quality (34/100), Value (36/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL.

Curiosis, Inc. develops, produces, and supplies laboratory equipment in the field of life science. It offers cell imaging, cell counting, cell isolation, and digital pathology products. The company was incorporated in 2015 and is based in Seoul, South Korea.

Key Financial Metrics

Price$17.61
Market Cap$130M
P/E (Forward)60.81
Price/Book7.21
Return on Equity-41.3%
Return on Invested Capital-24.6%
Debt/Equity11.77
Gross Margin43.4%
Operating Margin-140.2%
Revenue Growth-21.6%
Free Cash Flow$-3K

Curiosis operates in the Medical Devices industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Curiosis’s (494120.KQ) StockRank?
MoatMap’s StockRank for Curiosis (494120.KQ) is 12/100, with a Strong Sell signal. It is a composite of Quality (34), Value (36), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does Curiosis have an economic moat?
Curiosis (494120.KQ) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Curiosis a buy, hold, or sell?
MoatMap’s current signal for Curiosis (494120.KQ) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Curiosis in?
Curiosis (494120.KQ) operates in the Healthcare sector, specifically the Medical Devices industry (South Korea).
Browse all ranked stocks494120.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock